Finance

Lists
MKKGY:OTCMKTS
Merck KGaA
32,27 US$
+0,62%
(+0,20) 1D
16 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MKKGY...
Open
32,50 US$
High
32,53 US$
Low
32,24 US$
Mkt. cap
20,80 მლრდ.
Avg. vol.
126,28 ათ.
Volume
113,19 ათ.
Dividend
1,60%
Quarterly dividend
0,13 US$
Ex-dividend date
27 აპრ. 2026
P/E ratio
26,43
52-wk high
34,19 US$
52-wk low
23,73 US$
EPS
1,22 US$
Beta
0,93
Shares outstanding
646,21 მლნ.
No. of employees
62 ათ.
Open
32,50 US$
High
32,53 US$
Low
32,24 US$
Mkt. cap
20,80 მლრდ.
Avg. vol.
126,28 ათ.
Volume
113,19 ათ.
Dividend
1,60%
Quarterly dividend
0,13 US$
Ex-dividend date
27 აპრ. 2026
P/E ratio
26,43
52-wk high
34,19 US$
52-wk low
23,73 US$
EPS
1,22 US$
Beta
0,93
Shares outstanding
646,21 მლნ.
No. of employees
62 ათ.
News stories
From web sources and news partners
Profile
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Shizuoka and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India, and the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine. Merck was privately owned until going public on the Frankfurt Stock Exchange in 1995 and is listed on the DAX index of Germany's top companies. The Merck family still controls a majority of 70.3% of the company's shares. Wikipedia
About Merck KGaA
CEO-
Employees62,1 ათ.
Founded1668
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,32 მლრდ.
5,25 მლრდ.
5,13 მლრდ.
5,43 მლრდ.
Cost of goods sold
2,10 მლრდ.
2,20 მლრდ.
2,07 მლრდ.
2,27 მლრდ.
Cost of revenue
2,10 მლრდ.
2,20 მლრდ.
2,07 მლრდ.
2,27 მლრდ.
Research and development expenses
660,00 მლნ.
634,00 მლნ.
657,70 მლნ.
684,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,46 მლრდ.
1,54 მლრდ.
1,52 მლრდ.
1,56 მლრდ.
Operating expense
1,99 მლრდ.
2,12 მლრდ.
2,13 მლრდ.
2,41 მლრდ.
Total operating expenses
4,10 მლრდ.
4,32 მლრდ.
4,20 მლრდ.
4,68 მლრდ.
Operating income
1,22 მლრდ.
926,00 მლნ.
935,40 მლნ.
753,00 მლნ.
Other non operating income
1,00 მლნ.
4,00 მლნ.
-100,00 ათ.
-1,00 მლნ.
EBT including unusual items
1,12 მლრდ.
401,00 მლნ.
868,70 მლნ.
640,00 მლნ.
EBT excluding unusual items
1,12 მლრდ.
1,10 მლრდ.
867,50 მლნ.
640,00 მლნ.
Income tax expense
225,00 მლნ.
77,00 მლნ.
200,00 მლნ.
146,00 მლნ.
Effective tax rate
20,04%
19,20%
23,02%
22,81%
Other operating expenses
-128,00 მლნ.
-50,00 მლნ.
-45,40 მლნ.
164,00 მლნ.
Net income
902,00 მლნ.
319,00 მლნ.
659,40 მლნ.
490,00 მლნ.
Net profit margin
16,96%
6,08%
12,84%
9,02%
Earnings per share
-
-
-
2,16
Interest and investment income
27,00 მლნ.
21,00 მლნ.
21,20 მლნ.
25,00 მლნ.
Interest expense
-126,00 მლნ.
-43,00 მლნ.
-80,60 მლნ.
-137,00 მლნ.
Net interest expenses
-99,00 მლნ.
-22,00 მლნ.
-59,40 მლნ.
-112,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,68 მლრდ.
1,31 მლრდ.
1,42 მლრდ.
1,25 მლრდ.
Gain or loss from assets sale
-174,00 მლნ.
6,00 მლნ.
-41,90 მლნ.
1,00 მლნ.
AI content may include mistakes. Learn more
Google აპები